Neurol. praxi. 2026;27(4):278-283 | DOI: 10.36290/neu.2026.048

Functional jerks: diagnosis, communication of the diagnosis, and treatment

doc. MUDr. Tereza Serranová, Ph.D.
Neurologická klinika a Centrum klinických neurověd, Univerzita Karlova, 1. lékařská fakulta a Všeobecná fakultní nemocnice v Praze

Functional jerks (myoclonus) are among the less common subtypes of functional movement disorders and manifest as rapid, mostly paroxysmal involuntary movements. They may be spontaneous, present at rest, triggered by action, or elicited by external stimuli; they preferentially affect the trunk, limbs, and neck. The diagnosis is based primarily on positive signs of inconsistency of the jerks, such as variability in the pattern of muscle activation, duration, and triggering factors, and on neurophysiological evidence of cortical correlates preceding the jerks in EEG-EMG back-ave­raging studies. In treatment, the key elements are delivering a positive diagnosis, patient education, and individualized multidisciplinary therapy, usually including physiotherapy and psychotherapy.

Keywords: functional movement disorders, functional jerks, myoclonus, inconsistency, neurophysiology, Bereitschaftspotential, physiotherapy, psychotherapy.

Received: May 27, 2026; Revised: August 11, 2026; Accepted: August 24, 2026; Published: October 2, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Serranová T. Functional jerks: diagnosis, communication of the diagnosis, and treatment. Neurol. praxi. 2026;27(4):278-283. doi: 10.36290/neu.2026.048.
Download citation

References

  1. APA. Diagnostic and statistical manual of mental disorders. (5th ed.). 5th Edition ed. American Psychiatric Publishing: Arlington, VA 2013.
  2. Aybek S, Perez DL. Diagnosis and management of functional neurological disorder. Bmj. 2022;376:o64. Go to original source... Go to PubMed...
  3. Carson A, Lehn A. Epidemiology. Handb Clin Neurol. 2016;139:47-60. Go to original source... Go to PubMed...
  4. Carson A, Lehn A, Ludwig L, et al. Explaining functional disorders in the neurology clinic: a photo story. Pract Neurol. 2016;16(1):56-61. Go to original source... Go to PubMed...
  5. Drane DL, Fani N, Hallett M, et al. A framework for understanding the pathophysiology of functional neurological disorder. CNS Spectr. 2021;26(6):555-561. Go to original source... Go to PubMed...
  6. Dreissen YEM, Cath DC, Tijssen MAJ. Functional jerks, tics, and paroxysmal movement disorders. Handb Clin Neurol. 2016;139:247-258. Go to original source...
  7. Dreissen YEM, Dijk JM, Gelauff JM, et al. Botulinum neurotoxin treatment in jerky and tremulous functional movement disorders: a double-blind, randomised placebo-controlled trial with an open-label extension. J Neurol Neurosurg Psychiatry. 2019;90(11):1244-1250. Go to original source...
  8. Dreissen YEM, Gelauff JM, Tijssen MAJ. Functional Jerky Movements. In: LaFaver K, Maurer CW, Nicholson TR, et al. (eds). Functional Movement Disorder: An Interdisciplinary Case-Based Approach. Springer International Publishing: Cham. 2022:103-113. Go to original source...
  9. Edwards MJ, Adams RA, Brown H, et al. A Bayesian account of 'hysteria'. Brain. 2012;135(Pt 11):3495-3512. Go to original source...
  10. Forejtová Z, Serranová T, Sieger T, et al. The complex syndrome of functional neurological disorder. Psychol Med. 2023;53(7):3157-3167. Go to original source... Go to PubMed...
  11. Gelauff J, Stone J. Prognosis of functional neurologic disorders. Handb Clin Neurol. 2016;139:523-541. Go to original source...
  12. Gilmour GS, Langer LK, Bhatt H, et al. Factors Influencing Triage to Rehabilitation in Functional Movement Disorder. Mov Disord Clin Pract. 2024;11(5):515-525. Go to original source...
  13. Gupta A, Lang AE. Psychogenic movement disorders. Curr Opin Neurol. 2009;22(4):430-436. Go to original source...
  14. Gutkin M, McLean L, Brown R, et al. Systematic review of psychotherapy for adults with functional neurological disorder. J Neurol Neurosurg Psychiatry. 2021;92:36-44. Go to original source...
  15. Hallett M. Physiology of psychogenic movement disorders. Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia. 2010;17(8):959-965. Go to original source... Go to PubMed...
  16. Hallett M, Aybek S, Dworetzky BA, et al. Functional neurological disorder: new subtypes and shared mechanisms. Lancet Neurol. 2022;21(6):537-550. Go to original source... Go to PubMed...
  17. Latorre A, Ganos C, Hamada M, et al. Diagnostic Utility of Clinical Neurophysiology in Jerky Movement Disorders: A Review from the MDS Clinical Neurophysiology Study Group. Mov Disord Clin Pract. 2025;12(3):272-284. Go to original source...
  18. Ludwig L, Pasman JA, Nicholson T, et al. Stressful life events and maltreatment in conversion (functional neurological) disorder: systematic review and meta-analysis of case-control studies. Lancet Psychiatry. 2018;5(4):307-320. Go to original source...
  19. Marin-Medina DS, Zambrano JM, Espay AJ, et al. Systematic review of movement disorders mislabeled as functional: when incongruence misleads. J Neurol. 2026;273(5):256. Go to original source...
  20. Mavroudis I, Petridis F, Franekova K, et al. Prognosis and outcomes in functional neurological disorder: a PRISMA-compliant systematic review with subtype-specific synthesis and clinical translation. J Neurol. 2026;273(3):208. Go to original source... Go to PubMed...
  21. Nielsen G, Buszewicz M, Stevenson F, et al. Randomised feasibility study of physiotherapy for patients with functional motor symptoms. J Neurol Neurosurg Psychiatry. 2017;88(6):484-490. Go to original source... Go to PubMed...
  22. Nielsen G, Lee TC, Marston L, et al. Which factors predict outcome from specialist physiotherapy for functional motor disorder? Prognostic modelling of the Physio4FMD intervention. J Psychosom Res. 2025;190:112056. Go to original source...
  23. Nielsen G, Stone J, Lee TC, et al. Specialist physiotherapy for functional motor disorder in England and Scotland (Physio4FMD): a pragmatic, multicentre, phase 3 randomised controlled trial. Lancet Neurol. 2024;23(7):675-686. Go to original source... Go to PubMed...
  24. Parees I, Kassavetis P, Saifee TA, et al. Failure of explicit movement control in patients with functional motor symptoms. Mov Disord. 2013;28(4):517-523. Go to original source... Go to PubMed...
  25. Parees I, Kojovic M, Pires C, et al. Physical precipitating factors in functional movement disorders. J Neurol Sci. 2014;338(1-2):174-177. Go to original source... Go to PubMed...
  26. Perez DL, Aybek S, Popkirov S, et al. A Review and Expert Opinion on the Neuropsychiatric Assessment of Motor Functional Neurological Disorders. J Neuropsychiatry Clin Neurosci. 2021;33(1):14-26. Go to original source...
  27. Serranová T, Di Vico I, Tinazzi M. Functional Movement Disorder: Assessment and Treatment. Neurol Clin. 2023;41(4):583-603. Go to original source... Go to PubMed...
  28. Stone J. Incongruence in FND: time for retirement. Pract Neurol. 2024;24(2):163-165. Go to original source... Go to PubMed...
  29. van der Salm SM, Erro R, Cordivari C, et al. Propriospinal myoclonus: clinical reappraisal and review of literature. Neurology. 2014;83(20):1862-1870. Go to original source...
  30. WHO. International statistical classification of diseases and related health problems (11th ed.). 11 ed. Geneva; 2019.
  31. WHO. The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. 10 ed.: Geneva 1993.
  32. Zutt R, Elting JW, van der Hoeven JH, et al. Myoclonus subtypes in tertiary referral center. Cortical myoclonus and functional jerks are common. Clin Neurophysiol. 2017;128(1):253-259. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.